clorgyline has been researched along with Degenerative Diseases, Central Nervous System in 2 studies
Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Otto, R | 1 |
| Penzis, R | 1 |
| Gaube, F | 1 |
| Adolph, O | 1 |
| Föhr, KJ | 1 |
| Warncke, P | 1 |
| Robaa, D | 1 |
| Appenroth, D | 1 |
| Fleck, C | 1 |
| Enzensperger, C | 1 |
| Lehmann, J | 1 |
| Winckler, T | 1 |
| Fantacuzzi, M | 1 |
| Amoroso, R | 1 |
| Carradori, S | 1 |
| De Filippis, B | 1 |
1 review available for clorgyline and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy.
Topics: Humans; Neurodegenerative Diseases; Polyphenols; Resveratrol; Stilbenes; Structure-Activity Relation | 2022 |
1 other study available for clorgyline and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Evaluation of Homobivalent Carbolines as Designed Multiple Ligands for the Treatment of Neurodegenerative Disorders.
Topics: Animals; Carbolines; Cholinesterase Inhibitors; Computational Biology; Excitatory Amino Acid Antagon | 2015 |